{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:03:27Z","timestamp":1790546607381,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003091","name":"Educational Bureau of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jconrel.2017.06.027","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T18:31:00Z","timestamp":1498588260000},"page":"113-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"special_numbering":"C","title":["Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models"],"prefix":"10.1016","volume":"261","author":[{"given":"Yingying","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaishuai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.06.027_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2013.11.016","article-title":"Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery","volume":"174","author":"Park","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nbt1006-1211","article-title":"The emerging nanomedicine landscape","volume":"24","author":"Wagner","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0020","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current trends in the use of liposomes for tumor targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpb.2013.06.003","article-title":"Hyaluronic acid-coated liposomes for active targeting of gemcitabine","volume":"85","author":"Arpicco","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2017.06.027_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1039\/C2IB20135F","article-title":"Stimulus-responsive nanopreparations for tumor targeting","volume":"5","author":"Zhu","year":"2013","journal-title":"Integr. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2017.06.027_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2014.06.012","article-title":"Disulfide-containing parenteral delivery systems and their redox-biological fate","volume":"195","author":"Brulisauer","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/17425247.2013.783009","article-title":"Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy","volume":"10","author":"Sun","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumour microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0055","first-page":"307","article-title":"Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels","volume":"62","author":"Kuppusamy","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00003086-200203000-00028","article-title":"Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma","volume":"396","author":"Kim","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0065","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1038\/srep11365","article-title":"CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma","volume":"5","author":"Gao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0070","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1541-7786.MCR-13-0629","article-title":"CD44-Mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility","volume":"12","author":"Kim","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0075","first-page":"2592","article-title":"Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells","volume":"61","author":"Eliaz","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.addr.2015.11.011","article-title":"Hyaluronic acid for anticancer drug and nucleic acid delivery","volume":"97","author":"Dosio","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0085","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/mp2000428","article-title":"Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0090","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1021\/nn405839n","article-title":"Hyaluronan polymer length, grafting density, and surface poly (ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4419-0284-9_15","article-title":"Osteosarcoma: the COSS experience","volume":"152","author":"Bielack","year":"2009","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.clinthera.2014.02.018","article-title":"Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40years","volume":"36","author":"Sun","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biopha.2016.11.132","article-title":"Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle","volume":"85","author":"Fang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0110","first-page":"797","article-title":"The clinical value of CXCR4, HER2 and CD44 in human osteosarcoma: a pilot study","volume":"3","author":"Ma","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1211\/jpp.61.06.0003","article-title":"Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization","volume":"61","author":"Yu","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0120","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.nano.2015.06.011","article-title":"Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin","volume":"11","author":"Nguyen","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","article-title":"Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review","volume":"85","author":"Kanamala","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0130","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3109\/10717544.2014.990651","article-title":"Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity","volume":"23","author":"Tang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0135","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.biomaterials.2011.10.064","article-title":"Kim, polyethylene glycol-conjugated hyaluronic acid\u2013ceramide self-assembled nanoparticles for targeted delivery of doxorubicin","volume":"33","author":"Cho","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1211\/jpp.59.4.0001","article-title":"pH-sensitive liposomes-principle and application in cancer therapy","volume":"59","author":"Karanth","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.01.049","article-title":"Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy","volume":"225","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(99)00285-0","article-title":"Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan","volume":"66","author":"Lim","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation","volume":"229","author":"Ravar","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0160","series-title":"Methods in Bioengineering: Nanoscale Bioengineering and Nanomedicine","author":"Rege","year":"2014"},{"issue":"7","key":"10.1016\/j.jconrel.2017.06.027_bb0165","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s11095-015-1635-0","article-title":"Enhanced pH-responsiveness, cellular trafficking, cytotoxicity and long-circulation of pegylated liposomes with post-insertion technique using gemcitabine as a model drug","volume":"32","author":"Xu","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0170","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.biomaterials.2009.01.026","article-title":"Reduction-sensitive polymers and bioconjugates for biomedical applications","volume":"30","author":"Meng","year":"2009","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.jconrel.2017.06.027_bb0175","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1021\/bi980096y","article-title":"Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes","volume":"37","author":"Miller","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/0008-5472.CAN-03-0654","article-title":"Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes","volume":"15","author":"Eliaz","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jconrel.2017.06.027_bb0185","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbamem.2013.01.020","article-title":"Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity","volume":"1828","author":"Dalla Pozza","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0190","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2217\/nnm-2016-5000","article-title":"Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs","volume":"11","author":"Nascimento","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.jconrel.2017.06.027_bb0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12010-014-0740-6","article-title":"Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer","volume":"173","author":"Javid","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.colsurfb.2006.02.006","article-title":"Reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating","volume":"15","author":"Maeda","year":"2006","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/1061186021000072447","article-title":"Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models","volume":"10","author":"Gabizon","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.06.027_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2015.02.026","article-title":"Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in-vivo precipitation, superior to PEGylation","volume":"203","author":"Zhang","year":"2015","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.jconrel.2017.06.027_bb0215","doi-asserted-by":"crossref","first-page":"19634","DOI":"10.18632\/oncotarget.3839","article-title":"CD44 enhances tumor aggressiveness by promoting tumor cell plasticity","volume":"6","author":"Paulis","year":"2015","journal-title":"Oncotarget"},{"issue":"37","key":"10.1016\/j.jconrel.2017.06.027_bb0220","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1002\/smll.201501412","article-title":"A pH-responsive drug-delivery platform based on glycol chitosan-coated liposomes","volume":"11","author":"Yan","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0225","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2010.11.008","article-title":"Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles","volume":"155","author":"Ohya","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0230","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1021\/acsami.6b15105","article-title":"Robust, responsive and targeted PLGA anticancer nanomedicines by combining reductively cleavable surfactant and covalent hyaluronic acid coating","volume":"9","author":"Wu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.06.027_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2017.01.011","article-title":"Drug delivery research for the future: expanding the nano horizons and beyond","volume":"246","author":"Mitragotri","year":"2017","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2017.06.027_bb0240","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/natrevmats.2016.69","article-title":"Cancer nanomedicine: is targeting our target?","volume":"1","author":"Lammers","year":"2016","journal-title":"Nat. Rev. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917306922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917306922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:23:34Z","timestamp":1602375814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917306922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":48,"alternative-id":["S0168365917306922"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.027","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}